ALDX - What's Going On With Aldeyra Therapeutics Stock? | Benzinga
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares are trading higher Wednesday after the company announced that it entered into an exclusive options agreement with AbbVie.
What To Know:
Under the terms of the option agreement, AbbVie has the option to acquire a co-exclusive license to develop, manufacture and commercialize reproxalap in the U.S. and an exclusive license to develop, manufacture and commercialize reproxalap outside the U.S. Aldeyra will receive a non-refundable option fee ...